Royalty Pharma plc - Class A — Balance Sheet (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B Total liabilities 6.12 B7.27 B7.29 B6.3 B7.88 B9.91 B Total equity 9.9 B10.25 B9.53 B10.08 B10.34 B9.71 B Total liabilities & shareholders' equities 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B Total debt —————— Net debt ——————

新闻

TD Cowen上调Royalty Pharma目标价至50美元,看好增长前景

TD Cowen raises Royalty Pharma stock price target to $50 on growth

Royalty Pharma股价触及52周高点46.14美元

Royalty Pharma stock hits 52-week high at 46.14 USD

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

美银证券重申Royalty Pharma股票买入评级，目标价54美元

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

Royalty Pharma股价触及52周高点44.94美元

Royalty Pharma stock hits 52-week high at 44.94 USD

Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion